Bendroflumethiazide (versus unexposed)

Exposed non-exposed, cohort studies

Study Country
Study period
Study design
Data source Exposure definition Non-exposure definition Exposition period Sample size
(exposed/unexposed) Or (case / control)
Remarks Risk of bias
Leather
1968
United Kingdom
Not specified.
randomized controlled trial
Department of Clinical research, Plymouth general hospital, United Kingdom. Pregnant patients with early hypertension (before 20 gestational weeks) randomly allocated to treatment group, i.e bendrofluazide 5-10 mg daily with potassium supplements and methyldopa 0-5-2g daily in divided doses. unexposed, sick
Pregnant patients with early hypertension (before 20 gestational weeks) randomly allocated to control group.
during pregnancy (anytime or not specified) 23 / 24 Data related to chronic hypertension were reported here.
On entry to the trial patients were allocated at random to control or treatment groups.

Case-control studies

Study Country
Study period
Study design
Data source Case Control Exposition Exposition period Sample size
(exposed/unexposed) Or (case / control)
Remarks Risk of bias

Risk of bias: : NA;   : low;   : moderate;   : serious;   : critical;   : unclear;  

Empty. There are no case-control studies available for this drug.

master protocol